Clinical trial NCT01182987: SCAN Memory Program Evaluation Study
Official title: SCAN Memory Program Evaluation Study
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Dementia
Keywords: Quality improvement
Quality of care
Health care utilization
Behavioral change
Lead sponsor: VA Greater Los Angeles Healthcare System
Sponsor class: FED
Collaborators: name: University of California, Los Angeles
First posted: 2010-08-17
Enrollment: 500
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: The SCAN Memory Program Evaluation study is an evaluation of a randomized controlled trial intervention consisting of a care management program for cognitively-impaired health plan members and for their informal/family caregivers. The program includes collaboration between the health plan, partnering medical groups, and community organizations.

Program activities include: 1) telephonic-structured assessments with informal caregivers conducted by SCAN Memory Program care managers; 2) problem identification as a result of these assessments; and 3) pre-established protocols and procedures for problem resolution. ACCESS, the prototype for the SCAN Memory Program, was developed and tested in San Diego County and was very successful in helping affected patients and their caregivers.


Eligibility criteria: Inclusion Criteria: Health plan member eligibility includes having a visit-based ICD-9 diagnostic code for dementia or a dementia-specific medication (including donepezil, rivastigmine, galantamine, and memantine) within administrative data any time prior to data inquiry for potential subjects. The health plan member must have a caregiver who can communicate by telephone and though that person might also be a health plan member, health plan membership for caregivers is not required. All subjects must be living in the community and if in a nursing facility, this must be for rehabilitation or respite care but not for long term care. Caregivers must be able to communicate in English or Spanish.

Exclusion Criteria: Person with dementia whose potential participation is declined by their physician. Those who do not have a family or informal caregiver cannot participate and caregivers who do no have telephone access or the capacity to consent to research evaluation are excluded. Patients who reside in nursing facilities as permanent residents are not eligible.

-

Primary outcomes:
measure: Guideline Adherence
timeFrame: 18 months of longer
measure: Program feasibility and fidelity
timeFrame: 6 to 18 months
measure: Healthcare utilization
timeFrame: 18 months
Secondary outcomes:
measure: Behavioral disturbance
timeFrame: 9 months and 18 months
measure: Functional Status
timeFrame: 9 and 18 months
measure: Quality of life
timeFrame: 9 and 18 months
measure: Quality of Care
timeFrame: 9 and 18 months
measure: Caregiver self-efficacy
timeFrame: 9 months and 18 months
measure: Caregiver unmet need for assistance
timeFrame: 9 months and 18 months
measure: Caregiver social support
timeFrame: 9 months and 18 months
measure: Caregiver burden
timeFrame: 9 months and 18 months
measure: Caregiver depression
timeFrame: 9 months and 18 months
Other outcomes:
Locations:
city: Calabasas
country: United States
facility: Davis Research
state: California
city: Los Angeles
country: United States
facility: VA Greater Los Angeles Healthcare System
state: California
Study officials:
affiliation: VA / UCLA
name: Joshua Chodosh, MD, MSHS
role: PRINCIPAL_INVESTIGATOR
References: